OS9 anticorps (AA 101-200) (AbBy Fluor® 488)
-
- Antigène Voir toutes OS9 Anticorps
- OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))
-
Épitope
- AA 101-200
-
Reactivité
- Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp OS9 est conjugé à/à la AbBy Fluor® 488
-
Application
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Réactivité croisée
- Souris
- Homologie
- Human,Rat,Dog,Cow,Sheep,Horse,Rabbit
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human OS9
- Isotype
- IgG
- Top Product
- Discover our top product OS9 Anticorps primaire
-
-
- Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))
- Autre désignation
- OS9 (OS9 Produits)
- Synonymes
- anticorps OS-9, anticorps zgc:153838, anticorps 4632413K17Rik, anticorps AU022351, anticorps Os-9, anticorps ERLEC2, anticorps OS9, endoplasmic reticulum lectin, anticorps osteosarcoma amplified 9, endoplasmic reticulum lectin, anticorps amplified in osteosarcoma, anticorps OS9, anticorps os9, anticorps Os9
- Sujet
-
Synonyms: lied in osteosarcoma 9, amplied in osteosarcoma, OS-9, Os9, OS9_HUMAN, Protein OS-9.
Background: Lectin which functions in endoplasmic reticulum (ER) quality control and ER-associated degradation (ERAD). May bind terminally misfolded non-glycosylated proteins as well as improperly folded glycoproteins, retain them in the ER, and possibly transfer them to the ubiquitination machinery and promote their degradation. Possible targets include TRPV4.
- ID gène
- 10956
- Pathways
- Maintenance of Protein Location, SARS-CoV-2 Protein Interactome
-